{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:29:30Z","timestamp":1790882970186,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate access to prenatal care for pregnant patients receiving medication for opioid use disorder (MOUD) under Medicaid coverage in Florida.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A cross-sectional, secret shopper study was conducted in which calls were made to randomly selected obstetric clinicians' offices in Florida. Callers posed as a 14-week-pregnant patient with Medicaid insurance who was receiving MOUD from another physician and requested to schedule a first-time prenatal care appointment. Descriptive statistics were used to report our primary outcome, the callers' success in obtaining appointments from Medicaid-enrolled physicians' offices. Wait time for appointments and reasons the physician offices refused appointments to callers were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Overall, 2,816 obstetric clinicians are enrolled in Florida Medicaid. Callers made 1,747 attempts to contact 1,023 randomly selected physicians' offices from June to September 2021. Only 48.9% of medical offices (n=500) were successfully reached by phone, of which 39.4% (n=197) offered a prenatal care appointment to the caller. The median wait time until the first appointment was 15 days (quartile 1: 7; quartile 3: 26), with a range of 0\u201355 days. However, despite offering an appointment, 8.6% of the medical offices stated that they do not accept Medicaid insurance payment or would accept only self-pay. Among the 60.6% of callers unable to secure an appointment, the most common reasons were that the clinician was not accepting patients taking methadone (34.7%) or was not accepting any new patients with Medicaid insurance (23.8%) and that the pregnancy would be too advanced by the time of the first available appointment (7.3%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>This secret shopper study found that the majority of obstetric clinicians' offices enrolled in Florida Medicaid do not accept pregnant patients with Medicaid insurance who are taking MOUD. Policy changes are needed to ensure access to adequate prenatal care for patients with opioid use disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005315","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:06:05Z","timestamp":1697735165000},"page":"1162-1168","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Access to Prenatal Care Among Patients With Opioid Use Disorder in Florida"],"prefix":"10.1097","volume":"142","author":[{"given":"Kimberly","family":"Fryer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinyere N.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloni","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlynn","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Cogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pacheco Garrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Sappenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/EDE.0000000000001328","article-title":"Prenatal opioid analgesics and the risk of adverse birth outcomes","volume":"32","author":"Brogly","year":"2021","journal-title":"Epidemiology"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11920-019-1110-4","article-title":"Opioid use in pregnancy","volume":"21","author":"Tobon","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-244X-14-104","article-title":"Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis","volume":"14","author":"Baldacchino","year":"2014","journal-title":"BMC Psychiatry"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ADM.0000000000000534","article-title":"Continuation in treatment and maintenance of custody of newborns after delivery in women with opioid use disorder","volume":"14","author":"Schauberger","year":"2020","journal-title":"J Addict Med"},{"key":"R6-20260916","first-page":"e181","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion 711. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R9-20260916","first-page":"e202004b","article-title":"Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system","volume":"2020","author":"Madras","year":"2020","journal-title":"NAM Perspect"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"e2013456","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of pregnancy and insurance status with treatment access for opioid use disorder","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.whi.2021.03.010","article-title":"Reproductive-age women's experience of accessing treatment for opioid use disorder: we don't do that here","volume":"31","author":"Phillippi","year":"2021","journal-title":"Womens Health Issues"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ogc.2016.11.004","article-title":"Patient-centered care to address barriers for pregnant women with opioid dependence","volume":"44","author":"Sutter","year":"2017","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hec.3380","article-title":"The effects of prenatal care utilization on maternal health and health behaviors","volume":"26","author":"Yan","year":"2017","journal-title":"Health Econ"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ADM.0000000000000463","article-title":"Prenatal opioid exposure, neonatal abstinence syndrome\/neonatal opioid withdrawal syndrome, and later child development research: shortcomings and solutions","volume":"13","author":"Jones","year":"2019","journal-title":"J Addict Med"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/08897077.2020.1803178","article-title":"Identified gaps and opportunities in perinatal healthcare delivery for women in treatment for opioid use disorder","volume":"42","author":"Alexander","year":"2021","journal-title":"Substance Abuse"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jmwh.13019","article-title":"Maternity care for pregnant women with opioid use disorder: a review","volume":"64","author":"Rizk","year":"2019","journal-title":"J Midwifery Womens Health"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"777","DOI":"10.15585\/mmwr.mm6836a1","article-title":"State strategies to address opioid use disorder among pregnant and postpartum women and infants prenatally exposed to substances, including infants with neonatal abstinence syndrome","volume":"68","author":"Kroelinger","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/fampra\/cmab154","article-title":"Barriers to care for perinatal patients with opioid use disorder: family physician perspectives","volume":"39","author":"St Louis","year":"2022","journal-title":"Fam Pract"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"108765","DOI":"10.1016\/j.jsat.2022.108765","article-title":"You have to take this medication, but then you get punished for taking it: lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period","volume":"139","author":"Schiff","year":"2022","journal-title":"J Substance Abuse Treat"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"e196405","DOI":"10.1001\/jamanetworkopen.2019.6405","article-title":"Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population","volume":"2","author":"Azuine","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41372-019-0535-2","article-title":"Obstetrician-gynecologists' practice patterns related to opioid use during pregnancy and postpartum-United States, 2017","volume":"40","author":"Ko","year":"2020","journal-title":"J Perinatol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s40615-021-01095-4","article-title":"Treatment outcomes among Black adults receiving medication for opioid use disorder","volume":"9","author":"Parlier-Ahmad","year":"2022","journal-title":"J Racial Ethn Health Disparities"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.contraception.2018.06.011","article-title":"Access to emergency contraception in Kansas City clinics","volume":"98","author":"French","year":"2018","journal-title":"Contraception"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/AOG.0000000000002572","article-title":"An evaluation of the implementation of pharmacist-prescribed hormonal contraceptives in California","volume":"131","author":"Batra","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1370\/afm.2399","article-title":"Primary care appointments for Medicaid beneficiaries with advanced practitioners","volume":"17","author":"Leszinsky","year":"2019","journal-title":"Ann Fam Med"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10995-016-2155-1","article-title":"Trends in timing of pregnancy awareness among US women","volume":"21","author":"Branum","year":"2017","journal-title":"Matern Child Health J"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"e1920010","DOI":"10.1001\/jamanetworkopen.2019.20010","article-title":"Association of simulated patient race\/ethnicity with scheduling of primary care appointments","volume":"3","author":"Wisniewski","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1287\/msom.2021.0999","article-title":"Overbooked and overlooked: machine learning and racial bias in medical appointment scheduling","volume":"24","author":"Samorani","year":"2022","journal-title":"Manufacturing Serv Operations Manag"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/1475-6773.13089","article-title":"Are you accepting new patients? A pilot field experiment on telephone-based gatekeeping and Black patients' access to pediatric care","volume":"54","author":"Leech","year":"2019","journal-title":"Health Serv Res"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/birt.12551","article-title":"Health care system barriers and facilitators to early prenatal care among diverse women in Florida","volume":"48","author":"Reid","year":"2021","journal-title":"Birth"},{"key":"R39-20260916","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-012-2833-7","article-title":"Pharmacologic evidence to support clinical decision making for peripartum methadone treatment","volume":"225","author":"Bogen","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R40-20260916","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40501-020-00221-z","article-title":"Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum","volume":"7","author":"Martin","year":"2020","journal-title":"Curr Treat Options Psychiatry"},{"key":"R41-20260916","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007-2016","volume":"136","author":"Jarlenski","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R42-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40429-017-0132-4","article-title":"Psychiatric Co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment","volume":"4","author":"Arnaudo","year":"2017","journal-title":"Curr Addict Rep"},{"key":"R43-20260916","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"key":"R44-20260916","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: clinical and research issues","volume":"35","author":"Jones","year":"2008","journal-title":"J Substance Abuse Treat"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:05:59Z","timestamp":1789556759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005315"}},"subtitle":["Findings From a Secret Shopper Study"],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005315","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"2023-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}